Suzana M. Lobo

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

François-Xavier Lescure, Hitoshi Honda, Robert Fowler et al. · The Lancet Respiratory Medicine · 2021 · 248 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Variations in end-of-life practices in intensive care units worldwide (Ethicus-2): a prospective observational study

Alexander Avidan, Charles L. Sprung, Joerg C. Schefold et al. · The Lancet Respiratory Medicine · 2021 · 167 citations · Full text

Medicine, Internal Medicine, Critical Care Medicine +14

Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Alexander P. J. Vlaar, Martin Witzenrath, Pieter van Paassen et al. · The Lancet Respiratory Medicine · 2022 · 142 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +12

Randomized Trial of Molnupiravir or Placebo in Patients Hospitalized with Covid-19

José Ramón Arribas, Sanjay Bhagani, Suzana M. Lobo et al. · NEJM Evidence · 2021 · 128 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial

Iván O. Rosas, George Diaz, Robert Gottlieb et al. · Intensive Care Medicine · 2021 · 124 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14